• Fermium Research sets a price target of $50 for NYSE:LYB, indicating a potential upside of approximately 7.87%.
• LYB downgraded from a Buy to a Hold rating after a 22% decline in share price since May 2025.
• Despite challenges, LYB's financial health improves with better margins and cash flow, though it trades at a higher EV/EBITDA multiple of approximately 9.2x.

LyondellBasell Industries N.V. (NYSE:LYB) is a leading global chemical company that produces chemicals, polymers, and fuels. It operates in over 100 countries and serves industries such as packaging, electronics, and automotive. LYB faces competition from companies like Dow Inc. and BASF. On December 3, 2025, Fermium Research set a price target of $50 for LYB, while its stock was trading at $46.35, indicating a potential upside of approximately 7.87%.

Despite this optimistic price target, LYB has faced challenges. The stock has been downgraded from a Buy to a Hold rating after a failed contrarian call led to a 22% decline in its share price since May 2025. Currently, LYB's stock price is $46.02, reflecting a decrease of 3.68% or $1.76. During the trading day, the stock fluctuated between $45.95 and $48.53.

LYB's financial health shows signs of improvement, with better margins and cash flow. This is due to disciplined capital expenditures and a $1.1 billion cash improvement plan, which are essential for sustaining dividends. However, risks remain as LYB trades at a higher EV/EBITDA multiple of approximately 9.2x, driven by lower forward estimates and uncertainty in structural demand recovery.

The company's market capitalization is approximately $14.81 billion, with a trading volume of 5,960,429 shares on the NYSE. Over the past year, LYB's stock has seen a high of $80 and a low of $41.58. Despite recent setbacks, LYB's strategic initiatives aim to stabilize its financial position and support long-term growth.